Latest Strategy News

Anagenics Limited reports a marked reduction in cash outflows and operating costs following a strategic restructuring, with full benefits expected in the latter half of FY2025. Despite divesting Face Medi, core cosmetics sales remain steady.

True North Copper has successfully recapitalised following voluntary administration, securing a strong balance sheet and pivoting to an aggressive exploration strategy at its key Queensland copper projects.

Inventis Limited reported robust Q2 progress with over $5.7 million in confirmed orders and a $2.5 million capital raise underway in the US, signaling strong momentum in its technology-driven growth strategy.

Bass Oil Limited reported a 27% drop in quarterly revenue amid natural production declines but highlighted promising developments in its Kiwi gas field project in the Cooper Basin.

Manhattan Corporation has secured a pivotal Farm-In Agreement with Novo Resources for its Tibooburra Gold Project and gained surface access to progress drilling at its Chebogue Lithium Project in Canada, underpinning its exploration ambitions.

Alvo Minerals reports a 7.2Mt copper-equivalent resource at Palma and promising rare earth element drill results at Ipora, while launching a contracting division to offset costs.

A1 Investments & Resources Ltd reported a $36,000 net cash outflow for the September quarter, maintaining a slim cash balance of $2,000. The company is actively pursuing acquisitions and plans to raise $300,000 through convertible notes, pending shareholder approval.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

First Au Limited updates on its Victorian and Western Australian gold exploration projects, announces key board changes, and completes a $325,000 capital raise to support ongoing operations.

Cokal Limited has strengthened its position in Central Kalimantan through strategic partnerships with PT Petrindo and Cratus Group, securing US$20 million in funding to boost coal production and infrastructure development.

Freehill Mining Ltd’s December quarter cash flow report reveals a $114,000 net cash outflow from operations but highlights a solid liquidity position with $301,000 in unused financing facilities.

Tissue Repair Limited reports initial patient enrolment in its pivotal Phase 3 trial for TR987®, alongside a robust 35% quarterly sales increase for its TR Pro+® product. The company is also advancing manufacturing and distribution strategies to support growth.